Show simple item record

dc.contributor.authorJackson-Spence, FEen_US
dc.contributor.authorPowles, Ten_US
dc.contributor.authorLoriot, Yen_US
dc.contributor.authorToms, Cen_US
dc.contributor.authorJovaisaite, Aen_US
dc.contributor.authorChoy, Jen_US
dc.contributor.authorSzabados, BEen_US
dc.contributor.authorNudds, Hen_US
dc.contributor.authorAckerman, Cen_US
dc.contributor.authorMousa, Ken_US
dc.contributor.authorGrande, Een_US
dc.date.accessioned2023-03-30T08:40:40Z
dc.date.issued2022-11en_US
dc.identifier.issn1569-9056en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/85401
dc.format.extents219 - ?en_US
dc.publisherElsevieren_US
dc.relation.ispartofEuropean Urology Open Scienceen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.titleP126 Trial In Progress: DISCUS: A randomized phase II study comparing 3 vs. 6 cycles of platinum-based chemotherapy prior to maintenance avelumab in advanced urothelial canceren_US
dc.typeArticle
dc.identifier.doi10.1016/s2666-1683(22)02567-8en_US
pubs.notesNot knownen_US
pubs.volume45en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States